Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Phase 2 Active not recruiting 52 enrolled National Cancer Institute (NCI)

RandomizedParallel-groupDouble-blindPrevention

Summary

This phase II trial studies how well simvastatin works in preventing liver cancer in patients with liver cirrhosis. Simvastatin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Timeline

Start: 2017-06-21
Primary completion: 2023-05-03
Completion: 2026-12-23

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Simvastatin	Small molecule	—	Oral

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Summary

Timeline

Drugs

Indications